𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential

✍ Scribed by Marta A Crispens; Diane Bodurka; Michael Deavers; Karen Lu; Elvio G Silva; David M Gershenson

Book ID
117190444
Publisher
Lippincott Williams and Wilkins
Year
2002
Tongue
English
Weight
246 KB
Volume
99
Category
Article
ISSN
0029-7844

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Aberrant promoter methylation of multipl
Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential
✍ Andrew Wiley; Dionyssios Katsaros; Haigang Chen; Irene A. Rigault de la Longrais πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 217 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Methylation‐mediated suppression of detoxification, DNA repair, and tumor suppressor genes has been implicated in cancer development and progression. Studies also have indicated that concordant methylation of multiple genes (methylator phenotypes), rather than a single g

Ovarian papillary serous tumors of low m
Ovarian papillary serous tumors of low malignant potential (Serous borderline tumors): A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma
✍ Alexander W. Kennedy; William R. Hart πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 900 KB

## Background: The clinical outcome of patients with ovarian serous tumors of low malignant potential (lmp) remains controversial, especially for those with extraovarian disease. we retrospectively reviewed our experience to study this question further, to assess the safety of conservative manageme